Oromandibular Dystonia and Dysphagia in Hyperglycemic Brainstem Dysfunction
References
- 1Dubey S, Chatterjee S, Ghosh R, Louis DE, Hazra A, Sengupta S, et al. Acute onset movement disorders in diabetes mellitus: A clinical series of 59 patients. European Journal of Neurology. 2022;29(8):2241–8. DOI: 10.1111/ene.15353
- 2Girija SM, Yadav R, Nalini A, Annapureddy J, Gupta M, Mundlamuri CR, et al. Hyperglycemic Hyperosmolar Syndrome Presenting With Unique Craniofacial Involuntary Movements. Neurology Clinical Practice. 2021;11(6):10.1212/CPJ.000. DOI: 10.1212/CPJ.0000000000001004
- 3Chua C-B, Sun C-K, Hsu C-W, Tai Y-C, Liang C-Y, Tsai I-T. “Diabetic striatopathy”: clinical presentations, controversy, pathogenesis, treatments, and outcomes. Scientific Reports. 2020;10(1). DOI: 10.1038/s41598-020-58555-w
- 4Arecco A, Ottaviani S, Boschetti M, Renzetti P, Marinelli L. Diabetic striatopathy: an updated overview of current knowledge and future perspectives. Journal of Endocrinological Investigation. 2023;47(1):1–15. DOI: 10.1007/s40618-023-02166-5
- 5Dubey S, Biswas P, Ghosh R, Chatterjee S, Ray KB, Benito-León J. Neuroimaging of Diabetic Striatopathy: More Questions than Answers. European Neurology. 2022;85(5):371–6. DOI: 10.1159/000524936
- 6Souza DA, Desai KP. More often striatal myelinolysis than pontine? A consecutive series of patients with osmotic demyelination syndrome. Neurological Research. 2012;34(3):262–71. DOI: 10.1179/1743132812Y.0000000009
- 7Saini M, Mamauag M, Singh R. Central pontine myelinolysis: a rare presentation secondary to hyperglycaemia. Singapore Medical Journal. 2015;56(04):e71–e73. DOI: 10.11622/smedj.2015065
- 8Qu H-L, Sun X-Y, Dai Y-J. Central pontine myelinolysis: a rare finding in hyperosmolar hyperglycemia. Frontiers in Neurology. 2023;14. DOI: 10.3389/fneur.2023.1216328
- 9Chatterjee S, Ghosh R, Biswas P, Das S, Sengupta S, Dubey S, et al. Diabetic striatopathy and other acute onset de novo movement disorders in hyperglycemia. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2024;18(3):102997. DOI: 10.1016/j.dsx.2024.102997
- 10Beh CS. Temporal evolution of the trident and piglet signs of osmotic demyelination syndrome. Journal of the Neurological Sciences. 2017;373:268–73. DOI: 10.1016/j.jns.2017.01.024
- 11Burns DJ, Kosa CS, Wijdicks MFE. Central Pontine Myelinolysis in a Patient with Hyperosmolar Hyperglycemia and Consistently Normal Serum Sodium. Neurocritical Care. 2009;11(2):251–4. DOI: 10.1007/s12028-009-9241-9
- 12Nakanishi T, Tamaru S, Harada T, Shukuya K, Yamasato K, Kataoka J, et al. Osmotic Demyelination Syndrome in a Patient with Diabetic Ketoacidosis despite No Rapid Sodium Correction. Internal Medicine. 2024;63(11):1591–6. DOI: 10.2169/internalmedicine.2451-23
- 13Ambati R, Kho KL, Prentice D, Thompson A. Osmotic demyelination syndrome: novel risk factors and proposed pathophysiology. Internal Medicine Journal. 2023;53(7):1154–62. DOI: 10.1111/imj.15855
- 14Rodríguez-Velver VK, Soto-Garcia JA, Zapata-Rivera AM, Montes-Villarreal J, Villarreal-Pérez ZJ, Rodríguez-Gutiérrez R. Osmotic Demyelination Syndrome as the Initial Manifestation of a Hyperosmolar Hyperglycemic State. Case Reports in Neurological Medicine. 2014;2014:1–5. DOI: 10.1155/2014/652523
DOI: https://doi.org/10.5334/tohm.1062 | Journal eISSN: 2160-8288
Language: English
Submitted on: Jun 16, 2025
Accepted on: Jul 29, 2025
Published on: Aug 5, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2025 Gero Lueg, Timm Westhoff, Martin Fruth, Regina Kerkmann, Julia Krämer, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.